Families affected by fragile X syndrome can let out a modest cheer this week: the largest-ever randomized trial of a drug to treat the syndrome has just cleared its second phase.
The biology of obsessive-compulsive disorder becomes even more baffling with the release of two new mouse models, each implicating a different type of brain cell.
A clever new method records brain activity during live, back-and-forth social interactions and could help study joint attention — the act of looking at an object the same time someone else does.
A study of a rare form of epilepsy found in Amish groups adds heft to the idea that mTOR — a much-studied hub in a massive network of brain cell proteins — is an important biochemical player in autism.
The U.S. government last week announced a $1 million multi-agency initiative that will evaluate how many new ideas, jobs and medical advances have been generated by its investment into scientific research.
The challenge of finding jobs for adults with autism is the focus of a special issue of the Journal of Vocational Rehabilitation. With the right training and tools, the articles suggest, it's possible for many people with the disorder to be gainfully employed.
Charles Darwin performed what may be the world's first study of how people interpret and understand the emotions of others, according to a paper published in the Journal of the History of the Neurosciences.
The older a grandmother was when she bore her grandchild’s mother, the greater the child's risk of autism, according to a study published last month in PLoS One.
RSS
